Pharmacy Meeting Notices
This page contains the meeting notices for the Pharmaceutical and Therapeutics Committee, and the Drug Utilization Review Board. Please check here periodically for the latest meeting dates, times, and locations.
Drug Utilization Review (DUR) Board and Pharmaceutical and Therapeutics (P&T) Committee Meetings
The next meeting of the DUR Board is scheduled for:
Date: Thursday, June 26, 2025
Time: 1:30 PM – 4:30 PM Eastern Standard Time
Location: Virtual
Join from PC, Mac, iPad, or Android:
https://primetherapeutics.zoom.us/j/84699117463
Phone one-tap:
+17193594580,,84699117463# US
+12532050468,,84699117463# US
Join via audio:
+1 719 359 4580 US
+1 253 205 0468 US
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
+1 669 444 9171 US
+1 669 900 9128 US (San Jose)
+1 564 217 2000 US
+1 646 558 8656 US (New York)
+1 646 931 3860 US
+1 689 278 1000 US
+1 301 715 8592 US (Washington DC)
+1 305 224 1968 US
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
+1 360 209 5623 US
+1 386 347 5053 US
+1 507 473 4847 US
Webinar ID: 846 9911 7463
International numbers available: https://primetherapeutics.zoom.us/u/keaXv3zjgV
June 2024 DUR Agenda
[
90.2 kB
]
NOTE:
Public testimony requests for June 26, 2025, DUR Board meeting will be OPEN from 6:00AM ET on May 9, 2025, through Friday, May 30, 2025, at 9:00 AM ET. Those selected for public testimony must be present during the Webinar to speak. You will be notified of your selection status by 5:00PM ET on Friday, June 3, 2025
All interested parties can request a 2-minute speaker slot by completing the online form at:
https://forms.office.com/g/eW1Fv8H9MJ
Pharmaceutical and Therapeutics Committee
The next meeting of the P&T Committee is scheduled for:
Date: Friday, June 27, 2025
Time: 8:30 AM – 12:30 AM Eastern Standard Time
Location: Virtual
Join from PC, Mac, iPad, or Android:
https://primetherapeutics.zoom.us/j/82580569803
Phone one-tap:
+13462487799,82580569803# US (Houston)
+13602095623,82580569803# US
Join via audio:
+1 346 248 7799 US (Houston)
+1 360 209 5623 US
+1 386 347 5053 US
+1 507 473 4847 US
+1 564 217 2000 US
+1 646 558 8656 US (New York)
+1 646 931 3860 US
+1 669 444 9171 US
+1 669 900 9128 US (San Jose)
+1 689 278 1000 US
+1 719 359 4580 US
+1 253 205 0468 US
+1 253 215 8782 US (Tacoma)
+1 301 715 8592 US (Washington DC)
+1 305 224 1968 US
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
Webinar ID: 825 8056 9803
International numbers available: https://primetherapeutics.zoom.us/u/kl48ssu7d
Join from an H.323/SIP room system:
H.323:
144.195.19.161 (US West)
206.247.11.121 (US East) Meeting ID: 825 8056 9803
SIP: [email protected]
June 2024 P&T Agenda
[
404.1 kB
]
NOTE:
Public testimony requests for the June 27, 2025 P&T Committee meeting will be OPEN from 6:00AM ET on May 9, 2025, through Friday, May 30, 2025, at 9:00 AM ET. Those selected for public testimony must be present during the Webinar to speak. You will be notified of your selection status by 5:00PM ET on Friday, June 3, 2025
All interested parties can request a 2-minute speaker slot by completing the online form at:
https://forms.office.com/g/NXpwrx5CjP
